Notes to the Consolidated Financial Statements for the Year Ended 30 June 2014 NOTE 7: KEY MANAGEMENT PERSONNEL (b) Key management personnel remuneration includes the following expenses: NOTE 8: CASH AND CASH EQUIVALENTS 2014 2013 $ $ Short term employee benefits  Salaries including bonuses  1,859,719  1,252,095 Post-employment benefits  Superannuation  71,100  61,935 Share-based payments  348,013  492,976 Total Remuneration  2,278,832  1,807,006 Cash at bank  288,945  614,746 Deposits at call  31,070,254  972,553 31,359,199 1,587,299 Reconciliation of Cash Flow from Operations with Loss after Income Tax Loss after Income Tax  (7,039,109)  (3,487,960) Non-cash flows included in operating loss: Impairment - 1,503,296 Foreign exchange on intercompany balances  -  (1,526,215) Depreciation 12,808 29,794 Share-based payments  355,116  518,749 Foreign currency translation unrealised  8,761  (23,457) Changes in assets and liabilities: (Increase)/decrease in other assets  (2,936,521)  (13,163) Decrease in receivables  (16,514)  22,393 Decrease/(increase) in payables  277,246  200,452 Increase/(decrease) in employee provisions  67,874  43,515 Net cash flows from operations  (9,270,339)  (2,732,596) Page 30 Benitec Biopharma Ltd  Annual Report 2014 During the year no key management personnel exercised options which were granted either under ESOP or by a General Meeting of Members to  Non-Executive Directors (i) Non-Executive Directors  Mr Peter Francis  Chairman - Non-Executive  Appointed on 23 February 2006 Dr John Chiplin  Director - Non-Executive  Appointed on 1 February 2010 Mr Iain Ross  Director - Non-Executive  Appointed on 1 June 2010 Mr Kevin Buchi  Director - Non-Executive  Appointed on 11 April 2014 Dr Mel Bridges  Director - Non-Executive  Appointed on 12 October 2007 Resigned 18 June 2014  (ii) Specified Executives  Dr Peter French  Chief Executive Officer and Managing Director Appointed as Managing Director on 26 August 2014 Appointed Chief Executive Officer on 4 June 2010 Appointed Chief Scientific Officer on 4 August 2009 Dr Michael Graham  Chief Scientific Officer  Appointed on 1 January 2012 Mr Greg West  Company Secretary  Appointed on 26 May 2011 Mr Carl Stubbings  Chief Business Officer  Appointed on 2 July 2012 Dr David Suhy  Senior VP Research and Development Appointed on 1 October 2012 (a) Details of Key Management Personnel 